Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Cancer Chemotherapy and Pharmacology
|
February 4, 2012
Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations
V Ludovini, F Bianconi, L Pistola, et al.
Journal of Endocrinological Investigation
|
August 12, 1998
Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma
E Chiefari, D Russo, D Giuffrida, et al.
ESMO Open
|
April 5, 2021
COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the beginning of the first pandemic wave?
N Silvestris, M Di Maio, A Russo, et al.
Cancer Chemotherapy and Pharmacology
|
April 7, 2011
Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluation
Giulio Metro, R Chiari, M Mare, et al.
Breast Cancer Research and Treatment
|
August 15, 2013
Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study
M Campiglio, R Bufalino, M Sasso, et al.
Journal of Endocrinological Investigation
|
November 15, 2011
Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study
A Faggiano, P Ferolla, F Grimaldi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2019
Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy
L D Locati, A Piovesan, C Durante, et al.
ESMO Open
|
June 1, 2023
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view
A Natalicchio, M Montagnani, M Gallo, et al.
ESMO Open
|
December 9, 2023
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper
N Silvestris, T Franchina, M Gallo, et al.
Journal of Endocrinological Investigation
|
June 27, 2024
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view
A Natalicchio, N Marrano, M Montagnani, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Cancer Chemotherapy and Pharmacology
|
February 4, 2012
Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations
V Ludovini, F Bianconi, L Pistola, et al.
Journal of Endocrinological Investigation
|
August 12, 1998
Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma
E Chiefari, D Russo, D Giuffrida, et al.
ESMO Open
|
April 5, 2021
COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the beginning of the first pandemic wave?
N Silvestris, M Di Maio, A Russo, et al.
Cancer Chemotherapy and Pharmacology
|
April 7, 2011
Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluation
Giulio Metro, R Chiari, M Mare, et al.
Breast Cancer Research and Treatment
|
August 15, 2013
Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study
M Campiglio, R Bufalino, M Sasso, et al.
Journal of Endocrinological Investigation
|
November 15, 2011
Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study
A Faggiano, P Ferolla, F Grimaldi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2019
Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy
L D Locati, A Piovesan, C Durante, et al.
ESMO Open
|
June 1, 2023
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view
A Natalicchio, M Montagnani, M Gallo, et al.
ESMO Open
|
December 9, 2023
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper
N Silvestris, T Franchina, M Gallo, et al.
Journal of Endocrinological Investigation
|
June 27, 2024
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view
A Natalicchio, N Marrano, M Montagnani, et al.
Page
of 7